Who owns Revolution Medicines?
- Ticker: RVMD
- CUSIP Number: 76155x100
Tip: Access positions for across all investors
Analyze quarterly positions in Revolution Medicines with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revolution Medicines stock
Who bought or sold Revolution Medicines this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 14M | $2.6B | 22% | Jun 2026 |
|
| Farallon Capital Management | 14M | $2.5B | 0% | Jun 2026 |
|
| FMR | 12M | $2.3B | 44% | Jun 2026 |
|
| Baker Bros. Advisors | 11M | $2.1B | 20% | Jun 2026 |
|
| Jupiter Topco | 11M | $2.0B | 100% | Jun 2026 |
|
| Darwin Global Management | 11M | $2.0B | 381% | Jun 2026 |
|
| Henderson Group | 9.8M | $950M | 100% | Mar 2026 |
|
| Vanguard Capital Management | 9.1M | $1.7B | 9% | Jun 2026 |
|
| Vanguard Portfolio Management | 8.3M | $1.6B | 11% | Jun 2026 |
|
| Nextech Invest | 7.6M | $1.4B | 0% | Jun 2026 |
|
| Paradigm Biocapital Advisors | 6.4M | $1.2B | -4% | Jun 2026 |
|
| UBS Group | 5.5M | $1.0B | 24% | Jun 2026 |
|
| State Street Corporation | 4.4M | $428M | 7% | Mar 2026 |
|
| Geode Capital Management | 3.9M | $737M | 18% | Jun 2026 |
|
| Wellington Management Company | 3.8M | $720M | -36% | Jun 2026 |
|
| Jpmorgan Chase & Co | 3.3M | $635M | 100% | Jun 2026 |
|
| T. Rowe Price Associates | 3.2M | $314M | -5% | Mar 2026 |
|
| BVF | 3.0M | $555M | 4% | Jun 2026 |
|
| Alphabet | 2.9M | $552M | -11% | Jun 2026 |
|
| Casdin Capital | 2.6M | $483M | 0% | Jun 2026 |
|
| Deerfield Management Company | 2.4M | $448M | 4% | Jun 2026 |
|
| venBio Select Advisor | 2.3M | $430M | -2% | Jun 2026 |
|
| Caligan Partners | 2.2M | $415M | 18% | Jun 2026 |
|
| Norges Bank Investment Management | 2.2M | $404M | 100% | Jun 2026 |
|
| Goldman Sachs Group | 2.1M | $400M | -2% | Jun 2026 |
|
| Nearwater Capital Markets | 2.1M | $393M | 209% | Jun 2026 |
|
| Massachusetts Financial Services | 2.0M | $377M | 100% | Jun 2026 |
|
| Woodline Partners | 2.0M | $375M | -20% | Jun 2026 |
|
| Charles Schwab Investment Management | 1.9M | $359M | 10% | Jun 2026 |
|
| Sixth Street Partners Management Company | 1.9M | $359M | 100% | Jun 2026 |
|
| Susquehanna International | 1.9M | $351M | -16% | Jun 2026 |
|
| Integral Health Asset Management | 1.8M | $337M | -35% | Jun 2026 |
|
| Franklin Resources | 1.5M | $279M | 31% | Jun 2026 |
|
| Holocene Advisors | 1.4M | $255M | -45% | Jun 2026 |
|
| AQR Capital Management | 1.3M | $243M | 1009% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 1.3M | $242M | 14% | Jun 2026 |
|
| Citadel Advisors | 1.2M | $227M | 21% | Jun 2026 |
|
| Northern Trust | 1.1M | $209M | 17% | Jun 2026 |
|
| Rock Springs Capital Management | 1.1M | $207M | -9% | Jun 2026 |
|
| National Bank Of Canada /fi/ | 1.1M | $205M | -37% | Jun 2026 |
|
| Bellevue Group | 1.0M | $196M | -32% | Jun 2026 |
|
| Ameriprise Financial | 1.0M | $195M | -34% | Jun 2026 |
|
| Pictet Asset Management Holding SA | 1.0M | $191M | 82% | Jun 2026 |
|
| Bank of America Corporation | 984k | $184M | 60% | Jun 2026 |
|
| AH Capital Management | 921k | $173M | 0% | Jun 2026 |
|
| Ubs Global Asset Management Americas | 912k | $171M | 82% | Jun 2026 |
|
| Siren | 900k | $169M | -19% | Jun 2026 |
|
| Deutsche Bank Aktiengesellschaft | 888k | $166M | 91% | Jun 2026 |
|
| Caption Management | 877k | $164M | -43% | Jun 2026 |
|
| Lord, Abbett & Co | 789k | $148M | 488% | Jun 2026 |
|
| Dimensional Fund Advisors | 763k | $143M | -10% | Jun 2026 |
|
| Two Sigma Investments | 738k | $138M | -53% | Jun 2026 |
|
| Jane Street | 712k | $133M | 92% | Jun 2026 |
|
| Morgan Stanley | 706k | $69M | 8% | Mar 2026 |
|
| Logos Global Management | 700k | $131M | -65% | Jun 2026 |
|
| Polar Capital Holdings | 690k | $129M | -39% | Jun 2026 |
|
| Alyeska Investment Group | 659k | $124M | -65% | Jun 2026 |
|
| Bank of New York Mellon | 601k | $113M | -5% | Jun 2026 |
|
| Westfield Capital Management Company | 601k | $113M | -61% | Jun 2026 |
|
| Adage Capital Partners GP | 597k | $112M | -89% | Jun 2026 |
|
| Invesco | 578k | $108M | 47% | Jun 2026 |
|
| DAFNA Capital Management | 563k | $105M | -3% | Jun 2026 |
|
| Candriam Luxembourg S.C.A. | 556k | $104M | -4% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 553k | $104M | 31% | Jun 2026 |
|
| MIC Capital Management UK | 532k | $100M | -33% | Jun 2026 |
|
| Perceptive Advisors | 528k | $99M | 104% | Jun 2026 |
|
| Boothbay Fund Management | 521k | $98M | -39% | Jun 2026 |
|
| Boxer Capital Management | 500k | $94M | 0% | Jun 2026 |
|
| MPM Oncology Impact Management | 493k | $92M | -3% | Jun 2026 |
|
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne | 479k | $90M | 0% | Jun 2026 |
|
| Nuveen | 475k | $89M | 40% | Jun 2026 |
|
| Swiss National Bank | 456k | $86M | 7% | Jun 2026 |
|
| Vestal Point Capital | 450k | $84M | -81% | Jun 2026 |
|
| First Turn Management | 415k | $78M | -11% | Jun 2026 |
|
| Checkpoint Capital | 410k | $77M | 56% | Jun 2026 |
|
| Duquesne Family Office | 400k | $75M | 27% | Jun 2026 |
|
| Legal & General Group | 381k | $71M | 12% | Jun 2026 |
|
| General Atlantic | 358k | $67M | -49% | Jun 2026 |
|
| CalPERS | 350k | $66M | 24% | Jun 2026 |
|
| Partners HealthCare System | 344k | $34M | 0% | Mar 2026 |
|
| TCG Crossover Management | 341k | $64M | -41% | Jun 2026 |
|
| Qube Research & Technologies | 314k | $59M | -43% | Jun 2026 |
|
| Goodman & Company, Investment Counsel | 309k | $58M | 100% | Jun 2026 |
|
| Sumitomo Mitsui Trust Holdings | 306k | $57M | 13% | Jun 2026 |
|
| AIHC Capital Management | 303k | $57M | -63% | Jun 2026 |
|
| Jennison Associates | 281k | $53M | -9% | Jun 2026 |
|
| Patient Square Capital | 276k | $52M | 100% | Jun 2026 |
|
| Amundi | 270k | $51M | 95% | Jun 2026 |
|
| Baillie Gifford & Co | 264k | $49M | 41% | Jun 2026 |
|
| Millennium Management | 263k | $49M | -30% | Jun 2026 |
|
| Fred Alger Management | 260k | $49M | 1114% | Jun 2026 |
|
| Chicago Capital | 252k | $47M | 100% | Jun 2026 |
|
| Affinity Asset Advisors | 250k | $47M | 25% | Jun 2026 |
|
| Nicholas Investments Partners | 245k | $46M | -6% | Jun 2026 |
|
| Marshall Wace | 245k | $46M | 13% | Jun 2026 |
|
| Seven Fleet Capital Management | 242k | $45M | 200% | Jun 2026 |
|
| California State Teachers Retirement System | 239k | $45M | 44% | Jun 2026 |
|
| Victory Capital Management | 231k | $43M | 62% | Jun 2026 |
|
| Eventide Asset Management | 228k | $43M | -13% | Jun 2026 |
|
| Royal Bank of Canada | 226k | $42M | -39% | Jun 2026 |
|
| Rhumbline Advisers | 226k | $42M | 26% | Jun 2026 |
|
| Marsico Capital Management | 220k | $41M | 0% | Jun 2026 |
|
| Peak6 | 215k | $40M | 955% | Jun 2026 |
|
| Handelsbanken Fonder AB | 212k | $40M | 244% | Jun 2026 |
|
| Fisher Investments | 208k | $39M | -4% | Jun 2026 |
|
| Assenagon Asset Management | 201k | $38M | 100% | Jun 2026 |
|
| Stempoint Capital | 190k | $36M | -50% | Jun 2026 |
|
| Mitsubishi UFJ Asset Management | 187k | $35M | 13% | Jun 2026 |
|
| Artia Global Partners | 185k | $35M | 48% | Jun 2026 |
|
| NWI Management | 180k | $34M | 100% | Jun 2026 |
|
| Wells Fargo & Company | 179k | $34M | 422% | Jun 2026 |
|
| Raymond James Financial | 174k | $33M | 27% | Jun 2026 |
|
| Man Group | 173k | $33M | -37% | Jun 2026 |
|
| Hood River Capital Management | 170k | $32M | 100% | Jun 2026 |
|
| Florida State Board of Administration | 162k | $30M | 12% | Jun 2026 |
|
| Ing Investment Management | 156k | $29M | 227% | Jun 2026 |
|
| TD Asset Management | 156k | $29M | -51% | Jun 2026 |
|
| Tri Locum Partners | 152k | $28M | 100% | Jun 2026 |
|
| Samlyn Capital | 151k | $28M | -59% | Jun 2026 |
|
| Partner Fund Management | 143k | $27M | 2% | Jun 2026 |
|
| Standard Life Aberdeen | 143k | $27M | 25% | Jun 2026 |
|
| Russell Investments | 142k | $27M | 43% | Jun 2026 |
|
| Diadema Partners | 139k | $26M | -33% | Jun 2026 |
|
| D. E. Shaw & Co | 138k | $26M | -87% | Jun 2026 |
|
| Abu Dhabi Investment Council Co P.J.S.C | 137k | $26M | -92% | Jun 2026 |
|
| New York State Common Retirement Fund | 132k | $25M | 6% | Jun 2026 |
|
| Melqart Asset Management | 121k | $23M | -55% | Jun 2026 |
|
| Gotham Asset Management | 121k | $23M | -4% | Jun 2026 |
|
| OrbiMed Advisors | 121k | $23M | 132% | Jun 2026 |
|
| Eagle Health Investments | 120k | $23M | 1% | Jun 2026 |
|
| Zweig-DiMenna Associates | 120k | $23M | 1350% | Jun 2026 |
|
| Trexquant Investment | 120k | $23M | 75% | Jun 2026 |
|
| Aviva | 118k | $22M | 450% | Jun 2026 |
|
| Trails Edge Capital Partners | 116k | $22M | -53% | Jun 2026 |
|
| LMR Partners | 116k | $22M | -66% | Jun 2026 |
|
| Van Eck Associates Corp. | 111k | $21M | 2% | Jun 2026 |
|
| Barclays | 111k | $21M | -71% | Jun 2026 |
|
| Neuberger Berman Group | 109k | $21M | 443% | Jun 2026 |
|
| Toroso Investments | 109k | $20M | -21% | Jun 2026 |
|
| Birnam Oak Advisors | 108k | $20M | -32% | Jun 2026 |
|
| Bnp Paribas Investment Partners | 107k | $20M | 1% | Jun 2026 |
|
| ING Groep | 103k | $19M | 0% | Jun 2026 |
|
| Opaleye Management | 100k | $19M | 0% | Jun 2026 |
|
| Parnassus Investments | 100k | $19M | 100% | Jun 2026 |
|
| Quadrature Capital | 93k | $17M | 456% | Jun 2026 |
|
| Vanguard Asset Management | 92k | $17M | 14% | Jun 2026 |
|
| Federated Investors | 91k | $17M | 100% | Jun 2026 |
|
| SEB Asset Management AB | 90k | $17M | 30% | Jun 2026 |
|
| Citigroup | 90k | $8.7M | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 88k | $16M | -35% | Jun 2026 |
|
| Defilade Capital Management | 83k | $16M | -74% | Jun 2026 |
|
| PSquared Asset Management | 81k | $15M | -41% | Jun 2026 |
|
| Empyrean Capital Partners | 75k | $14M | -26% | Jun 2026 |
|
| HealthInvest Partners AB | 73k | $14M | -88% | Jun 2026 |
|
| Worldquant Millennium Quantitative Strategies | 73k | $14M | -88% | Jun 2026 |
|
| Tema Etfs | 72k | $13M | -27% | Jun 2026 |
|
| Manufacturers Life Insurance Company | 59k | $11M | -58% | Jun 2026 |
|
| WCM Investment Management | 58k | $11M | -45% | Jun 2026 |
|
| Squarepoint Ops | 56k | $10M | -64% | Jun 2026 |
|
| Decheng Capital | 53k | $9.9M | -44% | Jun 2026 |
|
| Frontier Capital Management | 52k | $9.7M | -79% | Jun 2026 |
|
| a16z Perennial Management | 52k | $9.6M | -51% | Jun 2026 |
|
| Cinctive Capital Management | 27k | $5.0M | -72% | Jun 2026 |
|
| Ensign Peak Advisors | 25k | $4.7M | -89% | Jun 2026 |
|
| Balyasny Asset Management | 9.3k | $1.7M | -92% | Jun 2026 |
|
| American Century Companies | 5.1k | $957k | -98% | Jun 2026 |
|
Who sold out of Revolution Medicines?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Frazier Life Sciences Management | Mar 2026 | 676k | $66M |
| Lunate Capital | Mar 2026 | 549k | $53M |
| Voloridge Investment Management | Mar 2026 | 368k | $36M |
| Ikarian Capital | Mar 2026 | 258k | $25M |
| Verition Fund Management | Mar 2026 | 210k | $20M |
| Kynam Capital Management | Mar 2026 | 208k | $20M |
| Kite Lake Capital Management | Mar 2026 | 100k | $9.7M |
| Connor, Clark & Lunn Investment Management | Mar 2026 | 92k | $8.9M |